{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["de Prost N"],"funding":["EMERGEN consortium-ANRS Maladies Infectieuses Emergentes","EMERGEN consortium—ANRS Maladies Infectieuses Emergentes"],"pagination":["101"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11213836"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(1)"],"pubmed_abstract":["<h4>Background</h4>A notable increase in severe cases of COVID-19, with significant hospitalizations due to the emergence and spread of JN.1 was observed worldwide in late 2023 and early 2024. However, no clinical data are available regarding critically-ill JN.1 COVID-19 infected patients.<h4>Methods</h4>The current study is a substudy of the SEVARVIR prospective multicenter observational cohort study. Patients admitted to any of the 40 participating ICUs between November 17, 2022, and January 22, 2024, were eligible for inclusion in the SEVARVIR cohort study (NCT05162508) if they met the following inclusion criteria: age ≥ 18 years, SARS-CoV-2 infection confirmed by a positive reverse transcriptase-polymerase chain reaction (RT-PCR) in nasopharyngeal swab samples, ICU admission for acute "],"journal":["Annals of intensive care"],"pubmed_title":["Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024."],"pmcid":["PMC11213836"],"funding_grant_id":["ANRS0153"],"pubmed_authors":["Maury E","Thiery G","Rodallec A","Soulier A","Lier C","Le Hingrat Q","Pham T","Mourvillier B","Pawlotsky JM","Tuaillon E","de Montmollin N","de Prost N","SEVARVIR investigators","Hraeich S","Mekontso Dessap A","Pham TO","Beloncle F","Timsit JF","Damoisel C","Thille AW","Klouche K","Coudroy R","Grolhier C","la Combe B","Gasperment M","Mayaux J","Levy D","Chevrel G","Clergue C","Henry A","Jandeaux LM","Courdavault Vagh Weinmann L","Moisan A","L'Honneur AS","Kimmoun A","Beduneau G","Roger S","Razazi K","Thibaut V","Gaudry S","Garcia-Sanchez C","Audureau E","Daix T","Preau S","Guigon A","Marot S","Guillon A","Morand-Joubert L","Jochmans S","Charles PE","Haouisee S","Azoulay E","Lunel Fabiani F","Vallet S","Fourati S","Bay P","Arrive F","Tran A","Urbina T","le Rougemont A","Candace Dossou N","Brechot N","Colson P","Deroche L","Schvoerer E","Marchasson L","Pere H","Vabret A","Seng S","Thomin J","Dartevel A","Girault C","le Pape S","Andreoletti L","Grall M","Imbert BM","Luyt CE","Meziani F","Voiriot G","Henquell C","Hantz S","Boyer A","Leveque N","Plantier JC","Larrat S","Delamaire F","Fournier PE","Bocar Fofana D","Bernier J","Ait-Oufella H","Uhel F","Tamion F","Handala L","Canet E","Pillet S","Rodriguez C","Brichler S","Burrel S","du Cheyron D","Turpin M","Chaix ML","Contou D","Carpentier D","Chaghouri A","Guignon A","N'Debi M","Lepiller Q","Picard L","Pitsch A","Laugel E","Souweine B","Descamps D","Gault E","Hartard C","Fafi-Kremer S","Saccheri C","Salmona M","Darreau C","Pene F","Giordanengo V","Piton G","Mirand A","Joseph A","Sabah K","Aubron C","Bellaiche R"],"additional_accession":[]},"is_claimable":false,"name":"Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024.","description":"<h4>Background</h4>A notable increase in severe cases of COVID-19, with significant hospitalizations due to the emergence and spread of JN.1 was observed worldwide in late 2023 and early 2024. However, no clinical data are available regarding critically-ill JN.1 COVID-19 infected patients.<h4>Methods</h4>The current study is a substudy of the SEVARVIR prospective multicenter observational cohort study. Patients admitted to any of the 40 participating ICUs between November 17, 2022, and January 22, 2024, were eligible for inclusion in the SEVARVIR cohort study (NCT05162508) if they met the following inclusion criteria: age ≥ 18 years, SARS-CoV-2 infection confirmed by a positive reverse transcriptase-polymerase chain reaction (RT-PCR) in nasopharyngeal swab samples, ICU admission for acute ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jun","modification":"2026-07-15T13:55:29.179Z","creation":"2026-07-05T03:12:04.721Z"},"accession":"S-EPMC11213836","cross_references":{"pubmed":["38940865"],"doi":["10.1186/s13613-024-01319-w"]}}